NewAmsterdam Pharma Company N.V. Ordinary Shares
$36.15
USD
Last updated on --.
24h volume814.55K
24h highest36.2050 USD
24h lowest35.0000 USD
24h Price movement+2.02%


NAMS recent prices
24 Hours
+2.02%+$0.715
30 days
+17.93%+$5.461
60 days
+18.18%+$5.450
90 days
+4.76%+$1.631
Key data
Previous close35.4400 USD
Market cap4.18B USD
Volume814.55K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.7400 USD
Net income (FY)-203.82M USD
Revenue (FY)22.50M USD
Last report dateFeb 18, 2026
About NewAmsterdam Pharma Company N.V. Ordinary Shares
HeadquartersNARRDEN
Employees (FY)100.00
Revenue per employee (FY)225.03K USD
Net income per employee (FY)-2.04M USD
Listed onNasdaq
NAMS conversion tables
| 0.5 NAMS | 18.07 USD |
| 1 NAMS | 36.15 USD |
| 5 NAMS | 180.77 USD |
| 10 NAMS | 361.55 USD |
| 0.5 USD | 0.013829 NAMS |
| 1 USD | 0.027659 NAMS |
| 5 USD | 0.13829 NAMS |
| 10 USD | 0.27659 NAMS |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
NAMS is trading at $36.15, +2.02% over the last 24 hours. Track live moves on the price chart at the top of this page.
The NAMS stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. NAMS is currently trading at $36.15, +2.02% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on NAMS price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. NAMS's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from NAMS; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against NAMS's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
NewAmsterdam Pharma Company N.V. Ordinary Shares's market cap is currently 4.18B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume814.55K
24h highest36.2050 USD
24h lowest35.0000 USD
24h Price movement+2.02%


Start trade with NAMS Perpetual
Sign up to trade
















